Deprecated: Creation of dynamic property Responsive_Lightbox_Lite::$choices is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/responsive-lightbox-lite/responsive-lightbox-lite.php on line 470

Deprecated: Creation of dynamic property Responsive_Lightbox_Lite::$loading_places is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/responsive-lightbox-lite/responsive-lightbox-lite.php on line 475
Stock market announcements Archive - Page 23 of 27 - Lifecare
Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Deprecated: Creation of dynamic property WP_Thumb::$_file_path is deprecated in /var/www/vhosts/lifecare.attme.dev/httpdocs/wp-content/plugins/wp-thumb/wpthumb.php on line 111

Stock market announcement archive

September 25, 2020
Reference is made to the stock exchange announcement by Lifecare AS (the Company) August 6th, 2020 regarding the exercise of 325.826 share options with a strike price of NOK 0,40 per share option, by Islay Venture GmbH - a company controlled by the Company CSO Prof. Dr. Dr. med Andreas Pfützner. Based on authorization granted […]
Read more
September 7, 2020
The board of directors of Lifecare has appointed Joacim Holter as CEO for Lifecare with immidiate effect. Holter have been a member of the Lifecare BoD since 2011 and was the Chairman of the BoD from 2012 to 2016. Holter has solid experience from leading international companies from the R&D stage to a commercial operation. […]
Read more
August 25, 2020
Lifecare’s partner Digital Diagnostics AG has received approval for clinical tests from the responsible ethics committee and the Federal Institute for Drugs and Medical Devices (BfArM) in Germany. This is a decisive regulatory step in the ongoing regulatory process for the Digid Cantisense™ SARS-CoV-2 test in Germany. The Digid Cantisense ™ SARS-CoV-2 antigen test for […]
Read more
August 6, 2020
Lifecare’s Chief Scientific Officer, Prof. Dr. Dr. med Andreas Pfützner, hold share option rights both personally and through his company Islay Ventures GmbH. The share option agreement with Islay Ventures GmbH includes 521.321 share options in total and the exercise right is based on a detailed milestone plan. In addition, Islay Ventures GmbH hold 578.125 […]
Read more
June 17, 2020
Christian Saure har vært styreleder i Lifecare AS siden mai 2016. Han har varslet selskapet om at han ikke tar gjenvalg på årets generalforsamling og fratrer etter eget ønske pr 26.06.2020. I den forbindelse har Sterna Holding AS, et selskap 100 % eid av Christian Saure som er primærinnsider i Lifecare AS, den 15.06 og […]
Read more
June 15, 2020
Lifecare’s partner Digital Diagnostics AG seeks additional approval in Germany for corona virus rapid test – plan for scaling capacities with production partners in USA and Europe and aim to bring test to the market in millions. The Norwegian listed company Lifecare AS (LIFE-ME) has a 25% ownership in Digital Diagnostics AG which has developed […]
Read more
June 2, 2020
Scientific breakthrough: Lifecare’s partner Digital Diagnostics AG detects corona virus with rapid test, seeks FDA approval and plans to deliver units starting in July The Norwegian listed company Lifecare AS (LIFE-ME) has a 25% ownership in Digital Diagnostics AG which has successfully detected SARS-CoV-2 viruses using the revolutionary Cantisense™ technology at the Helmholtz Centre for […]
Read more
April 23, 2020
Sterna Holding AS, et selskap 100 % eid av Christian Saure som er styreformann og primærinnsider i Lifecare AS LIFE-ME) har 21. april og 22. april solgt 1.115.000 aksjer i Lifecare AS til kurs 3,4179. Salget skyldes en rebalansering av Sterna Holding AS sin investeringsportefølje. Etter salget eier Sterna Holding AS 2.235.000 aksjer i Lifecare […]
Read more